IGFs: function and clinical importance 3 Role of insulin‐like growth factor (IGF) II and IGF binding proteins in extrapancreatic tumour hypoglycaemia
- 1 December 1993
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 234 (6) , 543-552
- https://doi.org/10.1111/j.1365-2796.1993.tb01012.x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Case Report: Increased Insulin Sensitivity in Tumor Hypoglycemia in a Diabetic Patient: Glucose Metabolism in Tumor HypoglycemiaThe Lancet Healthy Longevity, 1991
- Synthesis and Secretion of Insulin-like Growth Factor II by a Leiomyosarcoma with Associated HypoglycemiaNew England Journal of Medicine, 1988
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Hypoglycemia Associated with Non-Islet-Cell Tumor and Insulin-like Growth FactorsNew England Journal of Medicine, 1981
- Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.Journal of Clinical Investigation, 1981
- ECTOPIC INSULIN AND OCCAM'S RAZOR:* REAPPRAISAL OF THE RIDDLE OF TUMOUR HYPOGLYCAEMIAClinical Endocrinology, 1978
- Primary structure of human insulin‐like growth factor IIFEBS Letters, 1978
- The pathogenesis of tumour hypoglycaemia: Blocks of hepatic glucose release and of adipose tissue lipolysisDiabetologia, 1967
- The riddle of tumor hypoglycemiaThe American Journal of Medicine, 1966
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSPublished by Elsevier ,1963